Literature DB >> 30350920

Optimized Continuous Multicolumn Chromatography Enables Increased Productivities and Cost Savings by Employing More Columns.

Mark Pagkaliwangan1, Jonathan Hummel1, Xhorxhi Gjoka1, Marc Bisschops1, Mark Schofield1.   

Abstract

The advantages of continuous chromatography with respect to increased capacity are well established. However, the impact of different loading scenarios and total number of columns on the process economics has not been addressed. Here four different continuous multicolumn chromatography (MCC) loading scenarios are evaluated for process performance and economics in the context of a Protein A mAb capture step. To do so, a computational chromatography model is validated experimentally. The model is then used to predict process performance for each of the loading methods. A wide range of feed concentrations and residence times are considered, and the responses of operating binding capacity, specific productivity, and the number of process columns are calculated. Processes that are able to add more columns proved to be up to 65% more productive, especially at feed concentrations above 5 g L-1 . An investigation of the operating costs shows that discrete column sizing and process performance metrics do not always correlate and that the most productive process is not necessarily the most cost effective. However, adding more columns for the non-load steps at higher feed concentrations allows for overall cost savings of up to 32%.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  continuous chromatography; economics; multicolumn process

Mesh:

Substances:

Year:  2018        PMID: 30350920     DOI: 10.1002/biot.201800179

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  2 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Truly continuous low pH viral inactivation for biopharmaceutical process integration.

Authors:  Duarte L Martins; Jure Sencar; Nikolaus Hammerschmidt; Andreas Flicker; Johanna Kindermann; Thomas R Kreil; Alois Jungbauer
Journal:  Biotechnol Bioeng       Date:  2020-02-24       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.